Literature DB >> 7602387

Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism.

L G Raisz1.   

Abstract

Prostaglandins are potent regulators of bone formation and bone resorption that can have both stimulatory and inhibitory effects. They are likely to play a central role in the ability of the skeleton to respond to mechanical forces as well as to humoral mediators. The stimulatory and inhibitory responses appear to have different structure-activity relations and signal transduction pathways. Prostaglandin production by both bone and adjacent marrow cells is highly regulated by hormones, cytokines and growth factors, largely through changes in the inducible prostaglandin G/H synthase. Further studies of the role of prostaglandins in bone metabolism may lead to a better understanding of the physiologic and pathologic responses of the skeleton and to new approaches to metabolic bone diseases such as osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7602387     DOI: 10.1093/jn/125.suppl_7.2024S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  17 in total

1.  Pharmacological inhibition of intracellular calcium release blocks acid-induced bone resorption.

Authors:  Nancy S Krieger; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

2.  Mechanical loading regulates NFATc1 and beta-catenin signaling through a GSK3beta control node.

Authors:  Buer Sen; Maya Styner; Zhihui Xie; Natasha Case; Clinton T Rubin; Janet Rubin
Journal:  J Biol Chem       Date:  2009-10-19       Impact factor: 5.157

3.  Hormone-sensitive lipase-knockout mice maintain high bone density during aging.

Authors:  Wen-Jun Shen; Li-Fen Liu; Shailja Patel; Fredric B Kraemer
Journal:  FASEB J       Date:  2011-05-12       Impact factor: 5.191

4.  Dietary fat, saturated fatty acid, and monounsaturated fatty acid intakes and risk of bone fracture: a systematic review and meta-analysis of observational studies.

Authors:  H Mozaffari; K Djafarian; M D Mofrad; S Shab-Bidar
Journal:  Osteoporos Int       Date:  2018-06-12       Impact factor: 4.507

5.  Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS).

Authors:  P Vestergaard; P Hermann; J-E B Jensen; P Eiken; L Mosekilde
Journal:  Osteoporos Int       Date:  2011-06-28       Impact factor: 4.507

6.  Inhibition of the Prostaglandin EP-1 Receptor in Periosteum Progenitor Cells Enhances Osteoblast Differentiation and Fracture Repair.

Authors:  Marina Feigenson; Jennifer H Jonason; Jie Shen; Alayna E Loiselle; Hani A Awad; Regis J O'Keefe
Journal:  Ann Biomed Eng       Date:  2019-04-12       Impact factor: 3.934

7.  Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair.

Authors:  Xinping Zhang; Edward M Schwarz; Donald A Young; J Edward Puzas; Randy N Rosier; Regis J O'Keefe
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

8.  The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.

Authors:  S Kwan Tat; J-P Pelletier; D Lajeunesse; H Fahmi; M Lavigne; J Martel-Pelletier
Journal:  Clin Exp Rheumatol       Date:  2008 Mar-Apr       Impact factor: 4.473

9.  Resolvin D1 protects periodontal ligament.

Authors:  Manal Mustafa; Ahmed Zarrough; Anne Isine Bolstad; Henning Lygre; Kamal Mustafa; Hatice Hasturk; Charles Serhan; Alpdogan Kantarci; Thomas E Van Dyke
Journal:  Am J Physiol Cell Physiol       Date:  2013-07-17       Impact factor: 4.249

10.  Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors.

Authors:  Steeve Kwan Tat; Jean-Pierre Pelletier; Daniel Lajeunesse; Hassan Fahmi; Nicolas Duval; Johanne Martel-Pelletier
Journal:  Bone       Date:  2008-04-26       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.